NPM1 and acute myeloid leukemia: Nucleophosmin (NPM1) mutations are the most frequently recurring genetic abnormalities in patients with acute myeloid leukemia (AML), occurring in approximately 50% of adults and 20% of childhood AML with normal karyotypes1,2.